PC
Polar Capital Portfolio holdings
AUM
$13.5B
1-Year Return
55.85%
This Quarter Return
-13.7%
1 Year Return
+55.85%
3 Year Return
+125.38%
5 Year Return
+259.12%
10 Year Return
–
AUM
$9.35B
AUM Growth
-$2.4B
(-20%)
Cap. Flow
-$758M
Cap. Flow
% of AUM
-8.11%
Top 10 Holdings %
Top 10 Hldgs %
23.17%
Holding
296
New
31
Increased
109
Reduced
93
Closed
43
Top Buys
| 1 |
Danaher
DHR
|
$66.9M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
$61M |
| 3 |
Thermo Fisher Scientific
TMO
|
$51.3M |
| 4 |
Boston Scientific
BSX
|
$44.2M |
| 5 |
Arista Networks
ANET
|
$43.1M |
Top Sells
| 1 |
Merck
MRK
|
$115M |
| 2 |
Amgen
AMGN
|
$102M |
| 3 |
Apple
AAPL
|
$82.8M |
| 4 |
ATVI
Activision Blizzard Inc.
ATVI
|
$72.8M |
| 5 |
Flex
FLEX
|
$70.4M |
Sector Composition
| 1 | Technology | 25.49% |
| 2 | Financials | 23.49% |
| 3 | Healthcare | 21.31% |
| 4 | Communication Services | 7.67% |
| 5 | Consumer Discretionary | 6.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Bank of N.T. Butterfield & Son
NTB
$1.86B
| $5.02M | 0.05% |
+159,964
| New | +$5.02M |
|
|
GWPH
202
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $4.87M | 0.05% |
+50,000
| New | +$4.87M |
|
|
PPBI
203
DELISTED
Pacific Premier Bancorp
PPBI
| $4.81M | 0.05% |
188,340
+19,766
| +12% | +$504K |
|
204
Caterpillar
CAT
$198B
| $4.61M | 0.05% |
36,253
+5,261
| +17% | +$669K |
|
205
East-West Bancorp
EWBC
$14.8B
| $4.45M | 0.05% |
102,245
+5,798
| +6% | +$252K |
|
|
SIVB
206
DELISTED
SVB Financial Group
SIVB
| $4.21M | 0.05% |
22,141
-1,034
| -4% | -$196K |
|
|
TRHC
207
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $3.95M | 0.04% |
+62,004
| New | +$3.95M |
|
208
New Mountain Finance
NMFC
$1.13B
| $3.9M | 0.04% |
310,000
| – | – |
|
|
TWTR
209
DELISTED
Twitter, Inc.
TWTR
| $3.69M | 0.04% |
128,243
+46,243
| +56% | +$1.33M |
|
210
Helius Medical Technologies
HSDT
$6.4M
| – | – |
0
| – | – |
|
|
AERI
211
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $3.61M | 0.04% |
100,000
-25,000
| -20% | -$903K |
|
212
Zai Lab
ZLAB
$3.42B
| $3.48M | 0.04% |
+150,000
| New | +$3.48M |
|
213
Atlassian
TEAM
$45.2B
| $3.03M | 0.03% |
34,057
-33,359
| -49% | -$2.97M |
|
214
Golub Capital BDC
GBDC
$3.93B
| $2.89M | 0.03% |
178,675
-50,401
| -22% | -$814K |
|
|
SAGE
215
DELISTED
Sage Therapeutics
SAGE
| $2.87M | 0.03% |
30,000
-5,000
| -14% | -$479K |
|
|
PRNB
216
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
| $2.74M | 0.03% |
100,000
| – | – |
|
217
HDFC Bank
HDB
$361B
| $2.69M | 0.03% |
51,896
-814
| -2% | -$42.2K |
|
|
COHR
218
DELISTED
Coherent Inc
COHR
| $2.44M | 0.03% |
+23,075
| New | +$2.44M |
|
219
Q32 Bio
QTTB
$20.4M
| $2.24M | 0.02% |
+5,556
| New | +$2.24M |
|
|
OBSV
220
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $2.22M | 0.02% |
175,000
+25,000
| +17% | +$317K |
|
221
KVH Industries
KVHI
$116M
| $2.2M | 0.02% |
213,695
-302
| -0.1% | -$3.11K |
|
222
Amphenol
APH
$135B
| $1.92M | 0.02% |
94,588
-1,130,964
| -92% | -$22.9M |
|
223
Replimune Group
REPL
$494M
| $1.75M | 0.02% |
175,000
+25,000
| +17% | +$250K |
|
224
ProQR Therapeutics
PRQR
$258M
| $1.58M | 0.02% |
100,000
| – | – |
|
225
KalVista Pharmaceuticals
KALV
$796M
| $1.56M | 0.02% |
+78,900
| New | +$1.56M |
|